Free shipping on all orders over $ 500

 About 1 result found for searched term "1229575-09-0" (0.128 seconds)

Cat.No.  Name Target
M24582 Lenzilumab Anti-infection
KB 003
Lenzilumab (KB 003) is a humanized monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.